Advancements in Organ-on-a-Chip Technologies Reduce Reliance on Animal Testing

The article discusses the development and increasing adoption of organ-on-a-chip technologies, such as Harvard's Lung-on-a-Chip, as viable alternatives to animal testing in biomedical research. Regulatory bodies like the FDA are beginning to accept these methods, signaling a potential shift in toxicology and drug development practices.

Comments

Read original article